Nanomix Corporation (NNMX)
OTCMKTS: NNMX · Delayed Price · USD
0.0001
0.00 (0.00%)
Dec 29, 2023, 5:00 PM EDT - Market closed
Company Description
Nanomix Corporation develops and commercializes mobile point-of-care diagnostic system that is used in performing a range of in vitro diagnostic tests in various environments.
Its products are designed to enhance healthcare delivery by bringing diagnostic information to the point of initial patient interaction, whether in the hospital or in settings, such as nursing facilities, elderly homes, urgent care centers, airports, schools, and others.
The company is also developing a pipeline of other tests designed to enhance patient outcomes by making diagnostic information available.
Nanomix Corporation was founded in 2000 and is headquartered in San Leandro, California.
Nanomix Corporation
Country | MA |
Founded | 2000 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 30 |
CEO | David Gerald Ludvigson |
Contact Details
Address: 354 Merrimack Street, #4 Lawrence, Massachusetts 01843 United States | |
Phone | (603) 935-9799 |
Website | bostonti.com |
Stock Details
Ticker Symbol | NNMX |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001473579 |
CUSIP Number | 63008H201 |
ISIN Number | US63008H2013 |
Employer ID | 27-0801073 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Garrett P. Gruener | Founder and Executive Chairman |
David Gerald Ludvigson | Interim Chief Executive Officer, President, Secretary and Director |
Vidur Sahney | Chief Operating Officer |
Christopher R. Hetterly | Chief Financial Officer |
Bradley Johnson Ph.D. | Chief Technology Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Feb 6, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 24, 2023 | 8-K | Current Report |
May 15, 2023 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
Apr 7, 2023 | 10-K | Annual Report |
Mar 31, 2023 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
Mar 10, 2023 | 8-K | Current Report |
Feb 10, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Jan 25, 2023 | 8-K | Current Report |
Nov 14, 2022 | 10-Q | Quarterly Report |
Nov 10, 2022 | 8-K | Current Report |